Attached files

file filename
10-K - FORM 10-K - TRIMEDYNE INCtmed_10k-093012.htm
EX-32.1 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3201.htm
EX-32.2 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3202.htm
EX-31.2 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3102.htm
EX-31.1 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3101.htm
EXCEL - IDEA: XBRL DOCUMENT - TRIMEDYNE INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR8.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR1.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR5.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR3.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR4.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR7.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR9.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR6.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR41.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR18.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR53.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR54.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR47.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR19.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR16.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR17.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR52.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR33.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR37.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR34.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR51.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR49.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR12.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR21.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR38.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR15.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR22.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR14.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR45.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR44.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR25.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR42.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR39.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR32.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR48.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR10.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR36.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR40.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR55.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR46.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR35.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR28.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR20.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR24.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR23.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR30.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR27.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR11.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR13.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR31.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR26.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR29.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR43.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR50.htm
v2.4.0.6
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
Sep. 30, 2012
Sep. 30, 2011
ASSETS    
Cash and cash equivalents $ 472,000 $ 1,151,000
Trade accounts receivable, net of allowance for doubtful accounts of $11,000 for 2012 and 2011 493,000 598,000
Inventories 1,847,000 2,162,000
Other current assets 158,000 143,000
Total current assets 2,970,000 4,054,000
Property and equipment, net 751,000 1,027,000
Other 68,000 92,000
Goodwill 544,000 544,000
Total Assets 4,333,000 5,717,000
LIABILITIES AND STOCKHOLDERS' EQUITY    
Accounts payable 149,000 270,000
Accrued expenses 352,000 428,000
Deferred revenue 53,000 93,000
Accrued warranty 23,000 38,000
Current portion of note payable and capital leases 68,000 133,000
Note payable to related party 0 187,000
Accrued interest due to related party 0 1,000
Total current liabilities 645,000 1,150,000
Note payable and capital leases, net of current portion 0 13,000
Deferred rent 43,000 100,000
Total liabilities 688,000 1,263,000
Preferred stock - $0.01 par value, 1,000,000 shares authorized, none issued and outstanding 0 0
Common stock - $0.01 par value; 30,000,000 shares authorized,18,497,569 shares issued, 18,395,960 shares outstanding at September 30, 2012 and 2011. 186,000 186,000
Additional paid-in capital 51,295,000 51,268,000
Accumulated deficit (47,123,000) (46,287,000)
Stockholders' Equity before Treasury Stock 4,358,000 5,167,000
Treasury stock, at cost (101,609 shares) (713,000) (713,000)
Total stockholders' equity 3,645,000 4,454,000
Total liabilities and stockholder's equity $ 4,333,000 $ 5,717,000